119 related articles for article (PubMed ID: 32705892)
1. Molecular Insights and Functional Consequences of the Interaction of Heme with Activated Protein C.
Hopp MT; Alhanafi N; Paul George AA; Hamedani NS; Biswas A; Oldenburg J; Pötzsch B; Imhof D
Antioxid Redox Signal; 2021 Jan; 34(1):32-48. PubMed ID: 32705892
[No Abstract] [Full Text] [Related]
2. In-depth structure-function profiling of the complex formation between clotting factor VIII and heme.
Hopp MT; Ugurlar D; Pezeshkpoor B; Biswas A; Ramoji A; Neugebauer U; Oldenburg J; Imhof D
Thromb Res; 2024 May; 237():184-195. PubMed ID: 38631156
[TBL] [Abstract][Full Text] [Related]
3. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.
Mesters RM; Heeb MJ; Griffin JH
Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484
[TBL] [Abstract][Full Text] [Related]
4. Identification of a specific exosite on activated protein C for interaction with protease-activated receptor 1.
Yang L; Bae JS; Manithody C; Rezaie AR
J Biol Chem; 2007 Aug; 282(35):25493-500. PubMed ID: 17580306
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics and docking simulation of a natural variant of Activated Protein C with impaired protease activity: implications for integrin-mediated antiseptic function.
D'Ursi P; Orro A; Morra G; Moscatelli M; Trombetti G; Milanesi L; Rovida E
J Biomol Struct Dyn; 2015; 33(1):85-92. PubMed ID: 24251463
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C.
Gale AJ; Tsavaler A; Griffin JH
J Biol Chem; 2002 Aug; 277(32):28836-40. PubMed ID: 12063259
[TBL] [Abstract][Full Text] [Related]
7. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
Shen L; He X; Dahlbäck B
Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
[TBL] [Abstract][Full Text] [Related]
8. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition.
Dahlbäck B; Villoutreix BO
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1311-20. PubMed ID: 15860736
[TBL] [Abstract][Full Text] [Related]
9. Interactions and inhibition of blood coagulation factor Va involving residues 311-325 of activated protein C.
Mesters RM; Heeb MJ; Griffin JH
Protein Sci; 1993 Sep; 2(9):1482-9. PubMed ID: 8401232
[TBL] [Abstract][Full Text] [Related]
10. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
Nishioka J; Ido M; Hayashi T; Suzuki K
Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
[TBL] [Abstract][Full Text] [Related]
11. Zinc ions bind to and inhibit activated protein C.
Zhu T; Ubhayasekera W; Nickolaus N; Sun W; Tingsborg S; Mowbray SL; Schedin-Weiss S
Thromb Haemost; 2010 Sep; 104(3):544-53. PubMed ID: 20664913
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms that regulate the anticoagulant function of coagulation factor V.
Thorelli E
Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
[TBL] [Abstract][Full Text] [Related]
13. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity.
Zhang L; Jhingan A; Castellino FJ
Blood; 1992 Aug; 80(4):942-52. PubMed ID: 1498334
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel small molecule inhibitors of activated protein C.
Sperandio O; Wildhagen KC; Schrijver R; Wielders S; Villoutreix BO; Nicolaes GA
Thromb Res; 2014 Jun; 133(6):1105-14. PubMed ID: 24513148
[TBL] [Abstract][Full Text] [Related]
15. Exosite-dependent regulation of factor VIIIa by activated protein C.
Manithody C; Fay PJ; Rezaie AR
Blood; 2003 Jun; 101(12):4802-7. PubMed ID: 12595311
[TBL] [Abstract][Full Text] [Related]
16. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands.
Bangalore N; Drohan WN; Orthner CL
Thromb Haemost; 1994 Sep; 72(3):465-74. PubMed ID: 7855799
[TBL] [Abstract][Full Text] [Related]
17. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.
Gale AJ; Sun X; Heeb MJ; Griffin JH
Protein Sci; 1997 Jan; 6(1):132-40. PubMed ID: 9007985
[TBL] [Abstract][Full Text] [Related]
18. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
Geng JP; Cheng CH; Castellino FJ
Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
[TBL] [Abstract][Full Text] [Related]
19. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
Shen L; Dahlbäck B; Villoutreix BO
Biochemistry; 2000 Mar; 39(11):2853-60. PubMed ID: 10715104
[TBL] [Abstract][Full Text] [Related]
20. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
